SM-20302, A NOVEL GPIIB IIIA ANTAGONIST, HAS SHOWN A SELECTIVE ANTITHROMBOTIC ACTIVITY WITHOUT INCREASING THE RISK OF HEMORRHAGE IN-VIVO/

Authors
SAKURAMA T HORISAWA S KURATA H KISHIMOTO H NAKANO M FUKUOKA T KOHDA A KANEKO M
Citation
T. Sakurama et al., SM-20302, A NOVEL GPIIB IIIA ANTAGONIST, HAS SHOWN A SELECTIVE ANTITHROMBOTIC ACTIVITY WITHOUT INCREASING THE RISK OF HEMORRHAGE IN-VIVO/, Thrombosis and haemostasis, 1997, pp. 23-23
Citations number
NO
Categorie Soggetti
Hematology,"Peripheal Vascular Diseas
Journal title
Thrombosis and haemostasis → ACNP
ISSN journal
03406245
Year of publication
1997
Supplement
S
Pages
23 - 23
Database
ISI
SICI code
0340-6245(1997):<23:SANGIA>2.0.ZU;2-S